FierceBiotech 11 déc. 2025 Apple Tree Partners files for bankruptcy to keep cash flowing to portfolio biotechs
FierceBiotech 10 déc. 2025 Francis Medical gets FDA green light for water vapor ablation to treat prostate cancer
FierceBiotech 10 déc. 2025 Bleecker's big bang: Formation Bio unveils new subsidiary with $605M Lynk deal
FierceBiotech 10 déc. 2025 Sanofi, GSK ink preclinical pacts in quest for new autoimmune and cancer antibodies
FierceBiotech 10 déc. 2025 Chinese biotech led by AstraZeneca veteran reels in $108M for KRAS phase 3 plans
FierceBiotech 10 déc. 2025 Roche links oral SERD to 30% breast cancer risk reduction in phase 3 adjuvant trial
FierceBiotech 10 déc. 2025 Rainbows, pickleball and puppies: Inside the ‘enduring activism’ and ‘cautious optimism’ at ASH 2025
FierceBiotech 9 déc. 2025 Teleflex inks $2B in divestment deals for OEM, urology and acute care units
FierceBiotech 9 déc. 2025 ASH: J&J makes case for Tecvayli combo as an alternative to CAR-T in 2nd-line multiple myeloma
FierceBiotech 9 déc. 2025 Pfizer continues renewed obesity push with $150M upfront for Fosun unit's GLP-1 drug
FierceBiotech 9 déc. 2025 ASH: Exicure rebounds with phase 2 win, seeing 90% blood cell mobilization in myeloma
FierceBiotech 9 déc. 2025 Novartis pens $1.7B immuno-dermatology pact with AI-enabled British biotech
FierceBiotech 9 déc. 2025 FDA steers cancer CAR-T developers toward randomized superiority trials in policy shift